Physician treatment of metastatic triple-negative breast cancer in the immuno-oncology era: a discrete choice experiment.

MLA

Feinberg, Bruce, et al. “Physician Treatment of Metastatic Triple-Negative Breast Cancer in the Immuno-Oncology Era: A Discrete Choice Experiment.” Future Oncology (London, England), vol. 16, no. 33, Nov. 2020, pp. 2713–22. EBSCOhost, https://doi.org/10.2217/fon-2020-0729.

APA

Feinberg, B., Hime, S., Wojtynek, J., Dokubo, I., Gajra, A., Smith, Y., & Kish, J. (2020). Physician treatment of metastatic triple-negative breast cancer in the immuno-oncology era: a discrete choice experiment. Future Oncology (London, England), 16(33), 2713–2722. https://doi.org/10.2217/fon-2020-0729

Chicago

Feinberg, Bruce, Skyler Hime, Jeff Wojtynek, Igoni Dokubo, Ajeet Gajra, Yolaine Smith, and Jonathan Kish. 2020. “Physician Treatment of Metastatic Triple-Negative Breast Cancer in the Immuno-Oncology Era: A Discrete Choice Experiment.” Future Oncology (London, England) 16 (33): 2713–22. doi:10.2217/fon-2020-0729.